Johns Hopkins University Pediatric Gastroenterology

Fellowship · Baltimore, MD

Sponsored by Johns Hopkins University School of Medicine

Works by its people: 689
Authors: 38
First-author works: 169
Citations: 24,222

20112026

Topics

Inflammatory Bowel Disease 90
Hepatitis C virus research 50
Pediatric Hepatobiliary Diseases and Treatments 32
Genetic Syndromes and Imprinting 18
Liver Disease Diagnosis and Treatment 17
Clostridium difficile and Clostridium perfringens research 16
Cystic Fibrosis Research Advances 15
Cytomegalovirus and herpesvirus research 14
Liver Disease and Transplantation 14
Eosinophilic Esophagitis 13
Gastrointestinal motility and disorders 13
Clinical Nutrition and Gastroenterology 11

Most cited

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.
JAMA · 2023 · 176 citations · Barbara Haber
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Haematology · 2024 · 105 citations · Barbara Haber
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
The Journal of allergy and clinical immunology · 2023 · 115 citations · Tony Guerrerio
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.
The Journal of allergy and clinical immunology · 2025 · 29 citations · John Fortunato
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.
Hepatology (Baltimore, Md.) · 2023 · 77 citations · Wikrom Karnsakul
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.
The lancet. Gastroenterology & hepatology · 2024 · 46 citations · Wikrom Karnsakul
Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients.
The Pediatric infectious disease journal · 2024 · 31 citations · Barbara Haber
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Gastroenterology · 2024 · 40 citations · Shervin Rabizadeh

Topics

Inflammatory Bowel Disease 90

Hepatitis C virus research 50

Pediatric Hepatobiliary Diseases and Treatments 32

Genetic Syndromes and Imprinting 18

Liver Disease Diagnosis and Treatment 17

Clostridium difficile and Clostridium perfringens research 16

Cystic Fibrosis Research Advances 15

Cytomegalovirus and herpesvirus research 14

Liver Disease and Transplantation 14

Eosinophilic Esophagitis 13

Gastrointestinal motility and disorders 13

Clinical Nutrition and Gastroenterology 11

Most cited

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.

JAMA · 2023 · 176 citations · Barbara Haber

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Haematology · 2024 · 105 citations · Barbara Haber

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.

The Journal of allergy and clinical immunology · 2023 · 115 citations · Tony Guerrerio

Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meeting.

The Journal of allergy and clinical immunology · 2025 · 29 citations · John Fortunato

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study.

Hepatology (Baltimore, Md.) · 2023 · 77 citations · Wikrom Karnsakul

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.

The lancet. Gastroenterology & hepatology · 2024 · 46 citations · Wikrom Karnsakul

Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients.

The Pediatric infectious disease journal · 2024 · 31 citations · Barbara Haber

Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.

Gastroenterology · 2024 · 40 citations · Shervin Rabizadeh